GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Total Stockholders Equity

GRAIL (GRAL) Total Stockholders Equity : $2,503.4 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Total Stockholders Equity?

GRAIL's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $2,503.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. GRAIL's Book Value per Share for the quarter that ended in Dec. 2024 was $73.86. The ratio of a company's debt over equity can be used to measure how leveraged this company is. GRAIL's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.03.


GRAIL Total Stockholders Equity Historical Data

The historical data trend for GRAIL's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Total Stockholders Equity Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Total Stockholders Equity
-1,002.85 -1,212.53 4,646.16 3,646.19 2,503.41

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,646.19 3,991.06 2,695.13 2,587.64 2,503.41

GRAIL  (NAS:GRAL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

GRAIL's Book Value per Share for the quarter that ended in Dec. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

GRAIL's Debt-to-Equity for the quarter that ended in Dec. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GRAIL Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of GRAIL's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GRAIL Business Description

Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.